Polycythemia is associated with bone loss and reduced osteoblast activity in mice. - Wikidata - awgldk - TriplyDB

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

http://www.wikidata.org/entity/Q37656082

about

Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss.Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.

P2860

Q37144501-D0DFBB55-62AB-4517-8C08-17D305E90715 Q42784003-54987203-70C6-4D21-B0D2-89C4483CF4C9

P2860

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

http://www.wikidata.org/entity/Q37656082

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 December 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

@en

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

@nl

type

label

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

@en

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

@nl

prefLabel

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

@en

Polycythemia is associated with bone loss and reduced osteoblast activity in mice.

@nl

P1433

Q37656082-30E93D7D-8472-4EA4-AE40-A631CE0EAAF9

P1476

Q37656082-9FAEF082-D0CD-4022-A059-963B30DBB7D5

P2093

Q37656082-8636F381-B214-44BA-8D47-9208278B0A26

Q37656082-9DD398A8-1158-4FF4-8AF7-20284DD3ECBF

Q37656082-BE4B926B-4C2C-4B9E-A9E1-C51C5078B25A

Q37656082-E52F4F59-36F9-4D87-80B3-F0A4B16EBD09

Q37656082-F01FAA88-A3BF-4C8A-A80B-181B3D9809E1

P2860

Q37656082-002967C1-CB6C-4B93-B9DC-4D0AF20ED2F3

Q37656082-0137A55B-1151-421B-BD1C-1369B1C2196A

Q37656082-0801285D-E5F0-4B3F-B7FE-42AE8E3B0F51

Q37656082-132DA115-DA3C-4138-B496-9478086BA1D6

Q37656082-1D55DADC-39B4-472F-A3A1-4063FBD42C10

Q37656082-1E6AF2B8-107E-4AE0-BCA7-68FCF2AF0A15

Q37656082-2917144F-CE67-468A-94AE-FCA35D356E3D

Q37656082-2C52EF77-0D6B-4A47-8BB4-087953634710

Q37656082-2C906F11-F45D-4C76-8740-70442433F370

Q37656082-328EADD8-9316-4AF6-956C-7F162E7C1CA8

P2888

Q37656082-3F7289A8-0E44-4A45-B650-1A39A98DD630

P304

Q37656082-6573196A-5815-4BCA-BD88-6B43CCA54164

P31

Q37656082-03F7144C-7F95-4555-8E6B-5B2D7D9391EB

P356

Q37656082-FBFE60A5-68E5-42D1-9AAE-7ED120696A4E

P407

Q37656082-AA6225B5-2B15-49CD-82EE-E831E27869EE

P433

Q37656082-E7EAEC81-694A-40B1-9B6C-043B817350F2

P478

Q37656082-E90E8F66-D8A5-44BE-BC7D-6DC673D6D692

P50

Q37656082-571C5510-2487-418B-A6C7-1023BBB5E88B

Q37656082-EF293B01-D980-4C62-B5DA-9D4577AF9554

P577

Q37656082-1FA4100F-19E9-4271-8C85-9AF6395D1AF0

P698

Q37656082-96AF6D7E-7170-4909-8B9D-D59AAD5EC6F7

P921

Q37656082-9068D795-5D3E-43F4-8305-225DD908BC5C

P932

Q37656082-7C76AC78-D4C6-4796-8CE0-08B42027D62E

P356

S00198-015-3412-7

P1433

Osteoporosis International

P1476

Polycythemia is associated with bone loss and reduced osteoblast activity in mice

@en

P2093

C Casu

http://www.w3.org/2001/XMLSchema#string

J H Shim

http://www.w3.org/2001/XMLSchema#string

M G Vogiatzi

http://www.w3.org/2001/XMLSchema#string

P R Oikonomidou

http://www.w3.org/2001/XMLSchema#string

Z Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Osteoblastic cells regulate the haematopoietic stem cell niche

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats.

Bone disease in thalassemia: a frequent and still unresolved problem.

Erythropoietin couples hematopoiesis with bone formation

EPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesis

Changes in bone microarchitecture and biomechanical properties in the th3 thalassemia mouse are associated with decreased bone turnover and occur during the period of bone accrual.

P2888

s00198-015-3412-7

P304

1559-1568

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00198-015-3412-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Rivella

Bart J Crielaard

P577

2015-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26650379

http://www.w3.org/2001/XMLSchema#string

P921

P932

5319412

http://www.w3.org/2001/XMLSchema#string